Tag: diabetes
Study Examines Rates, Causes of ED Visits for Adverse Drug Events
The prevalence of emergency department (ED) visits for adverse drug events (ADEs) in the United States was estimated to be four per 1,000 individuals in 2013 and 2014, and the most common drug classes involved were anticoagulants,... read more
Diabetes monitoring breathalyzer developed
A new hand-held breathalyzer that allows individuals to easily assess their blood glucose levels has been developed. The device informs the user bout diabetes risk and it differs from a medical device we reported on earlier... read more
Low Blood Glucose Levels In Hospitalized Patients Linked To Increased Mortality Risk
Mortality risk was higher in insulin-treated patients with moderate hypoglycemia (40-70 mg/dL), compared to patients without insulin treatment with similar glucose values.... read more
A New Technology Sees Through Walls and May Save Your Life Someday
Where people can only see color through visible light in three bands - red, green and blue, hyperspectral imaging (HSI) divides the spectrum into dozens or hundreds of bands.... read more
8 changes to the Medicare Physician Fee Schedule in 2017
CMS issued its update to the 2017 Medicare Physician Fee Schedule. The changes include a number of new policies that reflect a broader agency-wide strategy to enhance quality, spend smarter and improve Americans' health.... read more
Insulin resistance reversed by removal of protein
By removing the protein galectin-3 (Gal3), a team of investigators led by University of California School of Medicine researchers were able to reverse diabetic insulin resistance and glucose intolerance in mouse models of... read more
Liraglutide increases heart rate in T2DM with stable CAD
Liraglutide increases heart rate (HR) and reduces heart rate variability (HRV) in overweight patients with newly diagnosed type 2 diabetes (T2D) and stable coronary artery disease (CAD).... read more
FDA approves automated insulin delivery device for type 1 diabetes
The Food and Drug Administration (FDA) has approved a device that automatically monitors blood glucose levels and delivers insulin when appropriate, for people aged 14 years and older who have type 1 diabetes.... read more
